查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1499414

胶原蛋白疾病血管疾病市场：按产品、适应症和最终用途 - 全球预测 2024-2030

Collagen Vascular Diseases Market by Product (Diagnosis, Treatments), Indication (Ankylosing Spondylitis, Dermatomyositis, Polyarteritis Nodosa), End-Use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

胶原病血管疾病市场规模预计2023年为298.3亿美元，2024年达322.1亿美元，预计2030年将达535.1亿美元，复合年增长率为8.70%。

胶原血管疾病是一组涉及支持器官和身体其他部位的富含蛋白质的组织的疾病。这种结缔组织对于皮肤、肌腱、骨骼、软骨和血管的强度、弹性和结构至关重要。胶原病血管疾病可能是遗传性的，也可能是由过度活跃的免疫系统引起的，导致身体攻击自身组织的自体免疫疾病。这些疾病通常具有通用特征，包括导致受影响器官和组织受损和功能障碍的发炎。此类别包括多种疾病，包括类风湿性关节炎、硬皮症、全身性红斑性狼疮、多发性肌炎、皮肌炎和全身性硬化症。胶原病血管疾病市场涵盖医疗解决方案的需求和供应，例如针对影响结缔组织的疾病的诊断、治疗、疗法和服务。该市场的应用包括临床诊断、治疗和持续的患者管理。最终使用者通常是医疗机构，例如医院、诊所、风湿病中心和居家照护机构。该市场也为研究和学术机构以及参与开发新治疗方法的製药和生物技术公司提供服务。影响胶原血管疾病市场需求的关键因素是：人们对胶原血管疾病的认识和理解不断提高、全球自体免疫疾病盛行率上升、医疗保健基础设施的改善以及医疗服务的可及性的改善。然而，他们面临挑战，例如与先进治疗和药物相关的高成本，以及严格的政府法规和核准流程。同时，胶原血管疾病的需求带来了一些快速增长的机会，包括基因治疗和干细胞治疗的进步，以及远端医疗、行动医疗应用和穿戴式装置在患者管理中的采用。

主要市场统计
基准年[2023] 298.3亿美元
预测年份 [2024] 322.1亿美元
预测年份 [2030] 535.1亿美元
复合年增长率（%） 8.70%

区域洞察

美国因其完善的医疗基础设施、患者意识以及自体免疫疾病的高盛行率而成为心血管疾病的重要市场。专注于技术创新的大型製药企业的存在和政府的支持政策正在促进市场的扩张。在南美洲，随着医疗保健的改善和人们对这种疾病的认识不断提高，胶原蛋白血管疾病市场正在扩大。政府加强医疗保健服务和医学研究国际合作的措施预计将进一步提振市场。欧盟对 KEYWORD 的需求的特征是全民健保系统的可用性以及对研究和开发的重视。严格的药品核准规定确保了高标准的医疗服务。该地区的消费者期待最先进的治疗设施，并受到治疗的功效和安全性的驱动。包括胶原血管疾病在内的自体免疫疾病在中东呈上升趋势，发展中的医疗保健产业高度依赖国际指南和药物。非洲治疗胶原血管疾病的能力各不相同，许多地区这些疾病的盛行率很高，而且缺乏先进的治疗方法。随着向现代医疗保健体系的过渡，中国市场正在迅速扩张，政府和私营部门对医疗保健的投资不断增加，全球药品的取得也不断改善，影响着客户的需求。日本市场反映了医疗保健领域技术整合的高水平，消费者基础倾向于创新和护理品质。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在胶原病血管疾病市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对胶原血管疾病市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争力的宝贵见解，包括研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对他们目前在胶原病血管疾病市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 提高对胶原血管疾病的认识与了解
      • 全球自体免疫疾病的发生率上升
      • 改善医疗基础设施并增加获得医疗服务的机会
    • 抑制因素
      • 与先进治疗和药物相关的高成本
    • 机会
      • 基因和干细胞治疗的持续进展
      • 部署远端医疗、行动医疗应用程式和穿戴式装置进行病患管理
    • 任务
      • 严格的政府法规和核准流程
  • 市场区隔分析
    • 产品：切片检查套件在胶原血管疾病的使用增加
    • 适应症：越来越多用于皮肌炎
    • 最终用途：扩大在诊断中心和实验室的用途，以诊断各种健康状况
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章胶原蛋白疾病血管疾病市场：副产品

  • 诊断
  • 治疗

第七章胶原蛋白疾病血管疾病市场（按适应症）

  • 僵直性脊椎炎
  • 皮肌炎
  • 结节性多动脉炎
  • 多发性肌炎
  • 干癣性关节炎
  • 復发性多发性软骨炎
  • 类风湿性关节炎
  • 硬皮症
  • 全身性红斑性狼疮
  • 血管炎

第八章胶原病血管疾病市场：依最终用途分类

  • 诊断中心及实验室
  • 医院/诊所

第九章 北美和南美胶原蛋白疾病血管疾病市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区胶原蛋白疾病血管疾病市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲胶原病血管疾病市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Quest Diagnostics 与 Cipher Medicine 合作，扩大类风湿性关节炎患者获得精准医疗的机会
    • FDA核准首个托珠单抗生物相似药用于治疗类风湿性关节炎、幼年类风湿性关节炎
    • 美国风湿病学会推出新套件来衡量类风湿性关节炎的结果
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-144C638C8F82

[184 Pages Report] The Collagen Vascular Diseases Market size was estimated at USD 29.83 billion in 2023 and expected to reach USD 32.21 billion in 2024, at a CAGR 8.70% to reach USD 53.51 billion by 2030.

Collagen vascular diseases comprise a group of disorders that involve the protein-rich tissue that supports organs and other parts of the body. This connective tissue is essential for the strength, elasticity, and structure of skin, tendons, bones, cartilage, and blood vessels. Collagen vascular diseases can be hereditary or caused by an overactive immune system, resulting in autoimmune conditions where the body attacks its own tissues. These diseases often share common features, including inflammation, which can damage and dysfunction of affected organs and tissues. The category encompasses a variety of conditions, including rheumatoid arthritis, scleroderma, systemic lupus erythematosus, polymyositis, dermatomyositis, and systemic sclerosis, among others. The market for collagen vascular diseases encompasses the demand and supply of medical solutions, including diagnostics, treatments, therapeutics, and services targeted towards diseases that affect connective tissue. Applications for this market include clinical diagnostics, therapeutic treatments, and ongoing patient management. End-users are typically healthcare facilities like hospitals, clinics, specialized rheumatology centers, and home care settings. This market also serves research and academic institutions and pharmaceutical and biotechnology companies involved in the development of new treatments. The key factors influencing the need for the collagen vascular diseases market include growing awareness and understanding of collagen vascular diseases, rising incidence of autoimmune diseases globally, improved healthcare infrastructure, and increased accessibility to medical services. However, the market faces challenges, such as high costs associated with advanced treatments and medications and stringent government regulations and approval processes. On the other hand, the need for collagen vascular diseases presents several burgeoning opportunities, such as ongoing advancements in gene and stem cell therapies and the adoption of telemedicine, mobile health applications, and wearables for patient management.

KEY MARKET STATISTICS
Base Year [2023] USD 29.83 billion
Estimated Year [2024] USD 32.21 billion
Forecast Year [2030] USD 53.51 billion
CAGR (%) 8.70%

Regional Insights

The United States represents a significant market for collagen vascular diseases (CVDs), driven by a well-established healthcare infrastructure, patient awareness, and a high incidence of autoimmune diseases. The presence of leading pharmaceutical companies focusing on innovation, coupled with supportive government policies, contributes to market expansion. In South America, the collagen vascular diseases market is expanding as healthcare access improves and the population becomes more aware of these diseases. Government initiatives to strengthen healthcare provision and international collaborations for medical research are expected to propel the market further. The EU's need for collagen vascular diseases is characterized by the availability of universal healthcare systems and a strong focus on research and development. Stringent regulations regarding drug approvals ensure a high standard of care. Consumers in this region expect state-of-the-art treatment facilities and are driven by the effectiveness and safety profiles of treatments. The Middle East is experiencing a rise in autoimmune disorders, including collagen vascular diseases, and due to a developing healthcare sector, there is a reliance on international guidelines and medications. Africa's capacity to manage collagen vascular diseases is varied, with a greater prevalence of these conditions and a scarcity of advanced treatments in many regions. China's market is rapidly expanding with a shift towards modern healthcare systems, and increased investment in healthcare by the government and private sector, paired with greater access to global pharmaceuticals, is influencing customer needs. Japan's market reflects a high degree of technological integration in healthcare, with a consumer base inclined towards innovation and treatment quality.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Collagen Vascular Diseases Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Growing awareness and understanding of collagen vascular diseases
      • Rising incidence of autoimmune diseases globally
      • Improved healthcare infrastructure and increased accessibility to medical services
    • Market Restraints
      • High cost associated with advanced treatments and medications
    • Market Opportunities
      • Ongoing advancements in gene and stem cell therapies
      • Adoption of telemedicine, mobile health applications, and wearables for patient management
    • Market Challenges
      • Stringent government regulations and approval processes
  • Market Segmentation Analysis
    • Product: Increasing usage of biopsy kits in collagen vascular diseases
    • Indication: Increasing utilization for indicating dermatomyositis
    • End-Use: Expanding usage among diagnostic centers & laboratories to diagnose various health conditions
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Collagen Vascular Diseases Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Collagen Vascular Diseases Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Quest Diagnostics and Scipher Medicine Collaborate to Scale Precision Medicine Access for Patients with Rheumatoid Arthritis

Quest Diagnostics and Scipher Medicine have forged a multi-year partnership to widen the scope of diagnostic capabilities for rheumatoid arthritis (RA) management, leveraging the pioneering PrismRA test. This molecular signature response classifier (MSRC) facilitates the prediction of responses to TNF inhibitor therapies, which is crucial for managing RA. Quest's service extension to include advanced RNA extraction and next-generation sequencing ensures a more efficient assessment of patient responses to TNF inhibitors. The partnership capitalizes on Quest's nationwide network for specimen collection and sophisticated logistics, thereby enhancing patient access to precision diagnostic solutions. [Published On: 2023-11-28]

FDA Approves First Tocilizumab Biosimilar For Treatment Of Rheumatoid Arthritis, JIA

Biogen has announced the FDA approval of Tofidence, the inaugural tocilizumab biosimilar authorized for use in the U.S., offering new treatment options for individuals with rheumatoid arthritis (RA) and certain juvenile arthritis conditions. This milestone promises increased healthcare savings and broader therapeutic access, according to the details provided by the manufacturer. Tofidence has been validated based on rigorous data analysis, including a phase 1 and phase 3 study, affirming its safety and efficacy as a biosimilar alternative to the reference drug Actemra. [Published On: 2023-10-02]

American College of Rheumatology Launches New Toolkit Aimed at Measuring Rheumatoid Arthritis Outcomes

The American College of Rheumatology (ACR) has introduced its innovative Rheumatoid Arthritis (RA) Measures Toolkit, a comprehensive resource designed to dramatically enhance the quality of RA patient care. Emphasizing the importance of regular monitoring and individualized therapy, the toolkit offers invaluable tools, including training guides, multilingual outcome measure copies, and workflow samples, to ensure precise and effective tracking of disease activity and patient functionality. [Published On: 2023-08-09]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Collagen Vascular Diseases Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Collagen Vascular Diseases Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Apollo Health and Lifestyle Limited, Augurex Life Sciences Corporation, Bayer AG, Beckman Coulter, Inc., Bio-Rad Laboratories Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb, Eli Lilly and Company, Exagen Inc., F. Hoffmann-La Roche Ltd, Getinge AB, Gilead Sciences, Inc., Illumina, Inc., Laboratory Corporation of America Holdings, LeMaitre Vascular, Inc., Merck KGaA, Novartis AG, PerkinElmer, Inc., Pfizer Inc,, QIAGEN GmbH, Siemens AG, Thermo Fisher Scientific, Inc., and Trinity Biotech PLC.

Market Segmentation & Coverage

This research report categorizes the Collagen Vascular Diseases Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Diagnosis
      • Biopsy
      • Blood Test
      • Echocardiogram
      • Imaging Tests
      • Urinalysis
    • Treatments
      • Medications
      • Physical Therapy
  • Indication
    • Ankylosing Spondylitis
    • Dermatomyositis
    • Polyarteritis Nodosa
    • Polymyositis
    • Psoriatic Arthritis
    • Relapsing Polychondritis
    • Rheumatoid Arthritis
    • Scleroderma
    • Systemic Lupus Erythematosus
    • Vasculitis
  • End-Use
    • Diagnostic Centers & Laboratories
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing awareness and understanding of collagen vascular diseases
      • 5.1.1.2. Rising incidence of autoimmune diseases globally
      • 5.1.1.3. Improved healthcare infrastructure and increased accessibility to medical services
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with advanced treatments and medications
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in gene and stem cell therapies
      • 5.1.3.2. Adoption of telemedicine, mobile health applications, and wearables for patient management
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations and approval processes
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing usage of biopsy kits in collagen vascular diseases
    • 5.2.2. Indication: Increasing utilization for indicating dermatomyositis
    • 5.2.3. End-Use: Expanding usage among diagnostic centers & laboratories to diagnose various health conditions
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Collagen Vascular Diseases Market, by Product

  • 6.1. Introduction
  • 6.2. Diagnosis
  • 6.3. Treatments

7. Collagen Vascular Diseases Market, by Indication

  • 7.1. Introduction
  • 7.2. Ankylosing Spondylitis
  • 7.3. Dermatomyositis
  • 7.4. Polyarteritis Nodosa
  • 7.5. Polymyositis
  • 7.6. Psoriatic Arthritis
  • 7.7. Relapsing Polychondritis
  • 7.8. Rheumatoid Arthritis
  • 7.9. Scleroderma
  • 7.10. Systemic Lupus Erythematosus
  • 7.11. Vasculitis

8. Collagen Vascular Diseases Market, by End-Use

  • 8.1. Introduction
  • 8.2. Diagnostic Centers & Laboratories
  • 8.3. Hospitals & Clinics

9. Americas Collagen Vascular Diseases Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Collagen Vascular Diseases Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Collagen Vascular Diseases Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Quest Diagnostics and Scipher Medicine Collaborate to Scale Precision Medicine Access for Patients with Rheumatoid Arthritis
    • 12.3.2. FDA Approves First Tocilizumab Biosimilar For Treatment Of Rheumatoid Arthritis, JIA
    • 12.3.3. American College of Rheumatology Launches New Toolkit Aimed at Measuring Rheumatoid Arthritis Outcomes
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. COLLAGEN VASCULAR DISEASES MARKET RESEARCH PROCESS
  • FIGURE 2. COLLAGEN VASCULAR DISEASES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. COLLAGEN VASCULAR DISEASES MARKET DYNAMICS
  • FIGURE 7. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. COLLAGEN VASCULAR DISEASES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. COLLAGEN VASCULAR DISEASES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COLLAGEN VASCULAR DISEASES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BLOOD TEST, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ECHOCARDIOGRAM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ECHOCARDIOGRAM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY IMAGING TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY URINALYSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY URINALYSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDICATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ANKYLOSING SPONDYLITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ANKYLOSING SPONDYLITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DERMATOMYOSITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DERMATOMYOSITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY POLYARTERITIS NODOSA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY POLYARTERITIS NODOSA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY POLYMYOSITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY POLYMYOSITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PSORIATIC ARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PSORIATIC ARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY RELAPSING POLYCHONDRITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY RELAPSING POLYCHONDRITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SCLERODERMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SCLERODERMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSTIC CENTERS & LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSTIC CENTERS & LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 136. AUSTRALIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 138. AUSTRALIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 140. AUSTRALIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 142. AUSTRALIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 145. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 146. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 147. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 148. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 149. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 150. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 151. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 152. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 153. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 154. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 155. INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 156. INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 157. INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 158. INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 159. INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 160. INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 161. INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 162. INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 163. INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 164. INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 165. INDONESIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 166. INDONESIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 167. INDONESIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 168. INDONESIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 169. INDONESIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 170. INDONESIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 171. INDONESIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 172. INDONESIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 173. INDONESIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 174. INDONESIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 175. JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 176. JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 177. JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 178. JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 179. JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 180. JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 181. JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 182. JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 183. JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 184. JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 185. MALAYSIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 186. MALAYSIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 187. MALAYSIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 188. MALAYSIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 189. MALAYSIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 190. MALAYSIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 191. MALAYSIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 192. MALAYSIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 193. MALAYSIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 194. MALAYSIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 196. PHILIPPINES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 198. PHILIPPINES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 200. PHILIPPINES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 202. PHILIPPINES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 203. PHILIPPINES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 204. PHILIPPINES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 205. SINGAPORE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 206. SINGAPORE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 207. SINGAPORE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 208. SINGAPORE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 209. SINGAPORE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 210. SINGAPORE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 211. SINGAPORE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 212. SINGAPORE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 213. SINGAPORE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 214. SINGAPORE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 216. SOUTH KOREA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 218. SOUTH KOREA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 220. SOUTH KOREA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 222. SOUTH KOREA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 224. SOUTH KOREA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 225. TAIWAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 226. TAIWAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 227. TAIWAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 228. TAIWAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 229. TAIWAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 230. TAIWAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 231. TAIWAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 232. TAIWAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 233. TAIWAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 234. TAIWAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 235. THAILAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 236. THAILAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 237. THAILAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 238. THAILAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 239. THAILAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 240. THAILAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 241. THAILAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 242. THAILAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 243. THAILAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 244. THAILAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 245. VIETNAM COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 246. VIETNAM COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 247. VIETNAM COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 248. VIETNAM COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 249. VIETNAM COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 250. VIETNAM COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 251. VIETNAM COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 252. VIETNAM COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 253. VIETNAM COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 254. VIETNAM COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 267. DENMARK COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 268. DENMARK COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 269. DENMARK COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 270. DENMARK COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 271. DENMARK COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 272. DENMARK COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 273. DENMARK COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 274. DENMARK COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 275. DENMARK COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 276. DENMARK COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 277. EGYPT COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 278. EGYPT COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 279. EGYPT COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 280. EGYPT COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 281. EGYPT COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 282. EGYPT COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 283. EGYPT COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 284. EGYPT COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 285. EGYPT COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 286. EGYPT COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 287. FINLAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 288. FINLAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 289. FINLAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 290. FINLAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 291. FINLAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 292. FINLAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 293. FINLAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 294. FINLAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 295. FINLAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 296. FINLAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 297. FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 298. FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 299. FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 300. FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 301. FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 302. FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 303. FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 304. FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 305. FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 306. FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 307. GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 308. GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 309. GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 310. GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 311. GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 312. GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 313. GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 314. GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 315. GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 316. GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 317. ISRAEL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 318. ISRAEL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 319. ISRAEL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 320. ISRAEL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 321. ISRAEL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
  • TABLE 322. ISRAEL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
  • TABLE 323. ISRAEL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 324. ISRAEL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 325. ISRAEL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 326. ISRAEL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 327. ITALY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 328. ITALY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 329. ITALY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 330. ITALY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2